TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18954518

Group type: EXPERIMENTAL
Intervention: Bilateral turbinoplasty combined with septoplasty
Number of subjects: 12

Group type: COMPARATOR
Intervention: No surgery on the inferior turbinates
Number of subjects: 12
Study: 16151760

Group type: EXPERIMENTAL
Intervention: 6 mg IV infused eletriptan
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6 mg SC sumatriptan
Number of subjects: 45

Group type: COMPARATOR
Intervention: SC placebo
Number of subjects: 45
Study: 11980385

Group type: EXPERIMENTAL
Intervention: Coca-Cola
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 11916912

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 9816521

Group type: EXPERIMENTAL
Intervention: Beta radiation (12, 14 or 16 Gy delivered with a 5 F non‐centered catheter)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Beta radiation (12, 14 or 16 Gy)
Number of subjects: 35
Study: 7654506

Group type: EXPERIMENTAL
Intervention: Thymopentin (50 mg s.c. every other day for 4 weeks post-splenectomy)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no thymopentin treatment)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Thymopentin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 2199642

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1.0 mg/kg/day for 3 days, then progressively decreased for 12 days)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 342624

Group type: COMPARATOR
Intervention: Inactivated influenza virus vaccines containing 200 or 400 chicken cell‐agglutinating units of both A/New Jersey/76 and A/Victoria/75 antigens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole‐virus vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subvirion vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Later revaccinations due to low titers of A/Victoria antibody
Number of subjects: 0
Study: 6752800

Group type: EXPERIMENTAL
Intervention: Vitrectomy for chronic cases of aphakic cystoid macular edema
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photocoagulation therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonrandomized, uncontrolled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized, controlled clinical studies
Number of subjects: 0
Study: 29096225

Group type: EXPERIMENTAL
Intervention: Mat-based Pilates training (60-min sessions, twice a week for 16 weeks)
Number of subjects: 61
Study: 27502478

Group type: EXPERIMENTAL
Intervention: Highest quartile of vitamin A intake
Number of subjects: 848

Group type: EXPERIMENTAL
Intervention: Highest quartile of vitamin A intake among participants with CFHY402H
Number of subjects: 848

Group type: EXPERIMENTAL
Intervention: Second highest quartile of vitamin A intake among participants with CFHY402H
Number of subjects: 848
Study: 24014392

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning with postconditioning (RIPC with RIPostC)
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning with postconditioning (RIPC with RIPostC) in off-pump coronary artery bypass surgery subgroup
Number of subjects: 1280
Study: 23136160

Group type: EXPERIMENTAL
Intervention: 32°C
Number of subjects: 36

Group type: COMPARATOR
Intervention: 34°C
Number of subjects: 36
Study: 20562430

Group type: EXPERIMENTAL
Intervention: IFNB-1b 50 microg
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: IFNB-1b 250 microg
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 18065407

Group type: EXPERIMENTAL
Intervention: high CHOEP (cyclophosphamide 1400 mg/m2, doxorubicin 65 mg/m2, vincristine 2 mg, etoposide 175 mg/m2 x3, prednisone 100 mg x5)
Number of subjects: 389

Group type: COMPARATOR
Intervention: CHOEP-21
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: high CHOEP
Number of subjects: 389
Study: 15809558

Group type: EXPERIMENTAL
Intervention: 50% VO2 reserve (LO)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 80% VO2 reserve (HI)
Number of subjects: 13
Study: 12887555

Group type: EXPERIMENTAL
Intervention: Subliminal stimulation with 'Mommy and I are one'
Number of subjects: 62

Group type: COMPARATOR
Intervention: Neutral stimulus 'People are walking'
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Potentially shame-inducing stimulus 'I am completely isolated'
Number of subjects: 62
Study: 10229306

Group type: EXPERIMENTAL
Intervention: Self-testing for postprandial glycosuria
Number of subjects: 6198
Study: 8686481

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol and clonazepam
Number of subjects: 28

Group type: COMPARATOR
Intervention: Lithium and clonazepam
Number of subjects: 28
Study: 2058571

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% of calories from carbohydrate)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat diet (60% of calories from fat)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mixed diet (45% of calories from fat)
Number of subjects: 8
Study: 6661892

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 250 mg/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ketoprofen 150 mg/day
Number of subjects: 47
Study: 29749805

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion (NAH w|lac)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline infusion (NAH w|placebo)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion (IAH w|lac)
Number of subjects: 13
Study: 29924160

Group type: EXPERIMENTAL
Intervention: Nursing interventions based on Imogene King's Theory of Goal Attainment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 27569177

Group type: EXPERIMENTAL
Intervention: Dance therapy (8-week, 3-times-per-week programme)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care (usual activities and medication)
Number of subjects: 67
Study: 22704138

Group type: EXPERIMENTAL
Intervention: Vigabatrin 3000 mg/day
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 20299044

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials reporting adverse event outcomes
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Harm reporting criteria satisfaction
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Studies addressing harm in various sections
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Specification of adverse events evaluated
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Timing of harm information collection
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Attribution of harm to intervention
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Reasons for patient withdrawal
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Reporting severity of adverse events
Number of subjects: 152
Study: 18036362

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 22275

Group type: COMPARATOR
Intervention: Control (placebo or no treatment)
Number of subjects: 22275
Study: 15606434

Group type: EXPERIMENTAL
Intervention: Aerodose Inhaler
Number of subjects: 22
Study: 12030732

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg t.i.d. for 12 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (healthy nonsmokers)
Number of subjects: 18
Study: 10492107

Group type: EXPERIMENTAL
Intervention: Oral 17beta‐oestradiol/oestriol (Trisequens) with norethisterone acetate
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐oestradiol (Estrapak) with norethisterone acetate
Number of subjects: 58
Study: 8684407

Group type: EXPERIMENTAL
Intervention: Terazosin (10 mg daily)
Number of subjects: 1229

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg daily)
Number of subjects: 1229

Group type: EXPERIMENTAL
Intervention: Combination of terazosin and finasteride
Number of subjects: 1229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1229
Study: 2018208

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg/20 min
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg/20 min
Number of subjects: 155

Group type: COMPARATOR
Intervention: 2.0 mg/kg/10 min
Number of subjects: 155
Study: 6786069

Group type: EXPERIMENTAL
Intervention: verapamil (400 +/- 80 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: nifedipine (82 +/- 31 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 10
Study: 31637608

Group type: EXPERIMENTAL
Intervention: Holistic Health Recovery Program (HHRP-A)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 243
Study: 29533255

Group type: EXPERIMENTAL
Intervention: 10% dextrose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20% dextrose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30% dextrose
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 27777129

Group type: EXPERIMENTAL
Intervention: 100mg aspirin
Number of subjects: 10120

Group type: EXPERIMENTAL
Intervention: 300mg aspirin
Number of subjects: 10120

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 10120

Group type: COMPARATOR
Intervention: 100mg aspirin, 300mg aspirin, matched placebo
Number of subjects: 10120
Study: 23870503

Group type: EXPERIMENTAL
Intervention: VIDSUN questionnaire
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Black race, BMI, suntan within the past year, sun exposure in the past 3 months, sunscreen use, and supplemental vitamin D intake
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Vitamin D intake from supplements
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Demographics and behaviors
Number of subjects: 609
Study: 22277663

Group type: EXPERIMENTAL
Intervention: Palonosetron (0.075 mg bolus)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ondansetron (8 mg bolus + 16 mg in PCA)
Number of subjects: 100
Study: 20530614

Group type: EXPERIMENTAL
Intervention: TES(60Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: TES(100Hz)
Number of subjects: 20
Study: 18496393

Group type: COMPARATOR
Intervention: Rectoanal inhibitory reflex (RAIR) assessment with balloon distention (10 to 50 mL) in constipation patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Volume of distention to achieve 50% relaxation in constipation patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Percentage of relaxation as a diagnostic tool for constipation
Number of subjects: 22
Study: 15925158

Group type: EXPERIMENTAL
Intervention: Mini-open blind technique (group A)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Limited open technique (group B)
Number of subjects: 185
Study: 12180224

Group type: EXPERIMENTAL
Intervention: Povidone-iodine antisepsis (Group B)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Antibacterial prophylaxis (1 g i.v. injection of cephradine at induction of anaesthesia) (Group C)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control (saline soaked gauze at the urethral meatus) (Group A)
Number of subjects: 167
Study: 10353581

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sublingual placebo
Number of subjects: 36
Study: 8845083

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diuretics
Number of subjects: 0
Study: 2015177

Group type: EXPERIMENTAL
Intervention: Clonidine (200 micrograms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine (22 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of clonidine and yohimbine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbachol
Number of subjects: 0
Study: 6128596

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31277532

Group type: EXPERIMENTAL
Intervention: Acupotomy-injection technique with targeted three-point
Number of subjects: 140

Group type: COMPARATOR
Intervention: Small needle knife therapy
Number of subjects: 140
Study: 27571713

Group type: EXPERIMENTAL
Intervention: Two Annurca apples per day
Number of subjects: 250

Group type: COMPARATOR
Intervention: Red Delicious, Granny Smith, Fuji, Golden Delicious (one apple per day each)
Number of subjects: 250
Study: 26263287

Group type: EXPERIMENTAL
Intervention: ShotBlocker with diclofenac sodium
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 22884611

Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts (MAS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 22152089

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F) 200/10 μg via metered-dose inhaler (MDI) BID
Number of subjects: 722

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/S) 250/50 μg via dry powder inhaler (DPI) BID
Number of subjects: 722
Study: 19776771

Group type: EXPERIMENTAL
Intervention: Anti-aggregation with dipyridamole and aspirin
Number of subjects: 0
Study: 17102242

Group type: EXPERIMENTAL
Intervention: Patient-Oriented education management system for diabetes (POEM)
Number of subjects: 0
Study: 15448954

Group type: EXPERIMENTAL
Intervention: Glucocorticoid therapy (GCC)
Number of subjects: 13
Study: 11695725

Group type: EXPERIMENTAL
Intervention: Fansidar
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 100
Study: 9222612

Group type: EXPERIMENTAL
Intervention: Social work interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social work activities
Number of subjects: 0
Study: 8591949

Group type: EXPERIMENTAL
Intervention: Combination regimens of sulfadoxine/pyrimethamine and chloroquine/clindamycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine monotherapy (45 mg/kg over 3 days)
Number of subjects: 0
Study: 2474057

Group type: EXPERIMENTAL
Intervention: LNH-84 regimen (ACVB) comprising doxorubicin 75 mg/m2, cyclophosphamide 1200 mg/m2, vindesine 2 mg/m2 x 2, bleomycin 10 mg x 2, prednisolone 60 mg/m2 x 5, followed by high-dose methotrexate, ifosfamide, etoposide, asparaginase, and cytarabine, with late intensification using AraCVmB.
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: LNH-84 regimen with late intensification
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: LNH-84 regimen
Number of subjects: 737
Study: 949589

Group type: EXPERIMENTAL
Intervention: Dichotic listening with paired linguistic stimuli
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dichotic listening with nonverbal material
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dichotic listening with randomly interspersed verbal and nonverbal pairs
Number of subjects: 60
Study: 31985275

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 28

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 28

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 28
Study: 31282921

Group type: EXPERIMENTAL
Intervention: Adjunctive corticosteroids (prednisolone acetate, 50 mg/d for 7 days) and other bundled interventions
Number of subjects: 816

Group type: COMPARATOR
Intervention: Control group (standard care without the bundled intervention)
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Adjunctive corticosteroids (intervention group)
Number of subjects: 816
Study: 25937159

Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 148

Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 148
Study: 23286834

Group type: EXPERIMENTAL
Intervention: 3 g/d of HMB-FA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21909614

Group type: EXPERIMENTAL
Intervention: Flowable composite as a liner
Number of subjects: 85

Group type: COMPARATOR
Intervention: Composite resin directly (Control)
Number of subjects: 85
Study: 18697386

Group type: EXPERIMENTAL
Intervention: Pedicular screw instrumentation at all pedicles in the fusion area (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Partial pedicular screw instrumentation (Group 2)
Number of subjects: 50
Study: 16219631

Group type: EXPERIMENTAL
Intervention: Fruits and Vegetables Make the Marks intervention (school-based fruit and vegetable intervention with home economics component and parental involvement)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Fruits and Vegetables Make the Marks intervention
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control schools (10 schools)
Number of subjects: 369
Study: 12688274

Group type: EXPERIMENTAL
Intervention: OxyArm device (group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Venturi mask (group 1)
Number of subjects: 40
Study: 11197192

Group type: EXPERIMENTAL
Intervention: Supervised toothbrushing on school‐days with a 1,000 ppm chalk‐based fluoride toothpaste for two years
Number of subjects: 461

Group type: COMPARATOR
Intervention: Control group (children who brushed once a day or less)
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Parental beliefs regarding time to check child's toothbrushing
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Toothbrushing charts as an incentive
Number of subjects: 461
Study: 8772758

Group type: EXPERIMENTAL
Intervention: Biphasic waveforms with 40%, 50%, 65%, 80%, 30%/50% tilt
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Biphasic waveforms with 65% tilt and 50‐ and 120‐microF capacitance
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 50‐microF capacitor
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Biphasic waveforms with 50% tilt and 40%/50% tilt
Number of subjects: 38
Study: 1505537

Group type: EXPERIMENTAL
Intervention: 4D taper (4 days; n = 7)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 8D taper (8 days; n = 6)
Number of subjects: 25

Group type: COMPARATOR
Intervention: CON (control, 4 days rest; n = 6)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: NOTAPER (non-taper, continued training; n = 6)
Number of subjects: 25
Study: 6833021

Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride, 5 grams qid during therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Diphenoxylate hydrochloride and atropine sulfate, 2.5‐20 mg per day (control) if diarrhea occurred
Number of subjects: 33
Study: 30980177

Group type: EXPERIMENTAL
Intervention: Baclofen plus risperidone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo plus risperidone
Number of subjects: 64
Study: 28847205

Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling (MOD-C)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vigorous sprint-interval cycling (VIG-SIC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both MOD-C and VIG-SIC
Number of subjects: 44
Study: 26577506

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (0.625 mg conjugated equine estrogen plus 2.5 mg medroxyprogesterone acetate)
Number of subjects: 16608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608
Study: 24215716

Group type: EXPERIMENTAL
Intervention: High doses of recombinant human follicle-stimulating hormone (rhFSH) 300 IU on alternate days for ≥4 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 21340657

Group type: EXPERIMENTAL
Intervention: Trolamine emulsion (prophylactic, every 8 hours, 4 hours apart from radiotherapy)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual supportive care (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trolamine emulsion
Number of subjects: 30
Study: 18513887

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) combined with regional hyperthermia (HT) using a higher RF-output power (>/=1,200 W)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Regional hyperthermia (HT)
Number of subjects: 35
Study: 17822466

Group type: EXPERIMENTAL
Intervention: Early intervention using vacuum erection device (VED) starting 1 month after RP, daily for 10 min/day for 5 months.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group using VED starting 6 months after RP.
Number of subjects: 28
Study: 16246664

Group type: EXPERIMENTAL
Intervention: Reality female condom
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reddy female condom
Number of subjects: 60
Study: 12035874

Group type: EXPERIMENTAL
Intervention: Long-acting calcium channel blockers (CCBs) such as nifedipine GITS, nitrendipine, and diltiazem
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Nifedipine GITS
Number of subjects: 4500
Study: 9697672

Group type: EXPERIMENTAL
Intervention: Synthetic urodilatin (URO) infusion at a low dose of 20 ng x kg(‐1) x min(‐1) for 60 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 24
Study: 10586205

Group type: EXPERIMENTAL
Intervention: rHuEpo (300 U/kg) three times a week for 8 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: rHuEpo + G‐CSF (1 microg/kg) three times a week for 8 weeks (added if PR or NR after rHuEpo)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: rHuEpo administration
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Scandinavian‐American response score > +1
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Scandinavian‐American response score <= 1
Number of subjects: 32
Study: 2518952

Group type: EXPERIMENTAL
Intervention: Whole virus vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fragmented virus vaccine
Number of subjects: 0
Study: 750603

Group type: EXPERIMENTAL
Intervention: Nicotinic acid (2 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31639321

Group type: COMPARATOR
Intervention: Control condition (no PrEP)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Baseline CARS measure
Number of subjects: 144